Stay updated on Dupilumab in COPD Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in COPD Clinical Trial page.

Latest updates to the Dupilumab in COPD Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays a 403 Forbidden error. The expected study details and related documents are removed, blocking access to the trial record.SummaryDifference17%

- Check31 days agoChange DetectedRevision label updated to v3.7.0, replacing the previous v3.6.6. This indicates a minor page release/update that does not alter the study details or user-facing content.SummaryDifference0.0%

- Check52 days agoChange DetectedA new NIH grant/contract note from 2018 was added, and a publication by Bhatt et al. on dupilumab in COPD was added to the Publications section. The revision history shows Revision: v3.6.6 and removes v3.6.5.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.4 to v3.6.5, indicating an updated version of the page. This update does not modify the study details presented to users.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in COPD Clinical Trial page.